Pro-Dex, Inc. PDEX
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +51.14%
- 1 year
- +89.88%
- Open
- 65.65
- Prev close
- 61.60
- Mkt cap
- 188.04M
- Vol
- 38.49K
- Avg vol
- 64.19K
- EPS
- 4.12
- P/E
- 14.12
- Div yield
- 0.00%
More statistics
- Low
- 58.00
- High
- 65.65
- Forward P/E
- 22.28
- Beta
- 0.39
- Short ratio
- 0.44
- Inst. own
- 27.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 41.69
- 200-d avg
- 25.75
- 1y target
- 52.00
News
2 days ago zacks.com
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates
Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.62 per share a year ago.
-
3 days ago benzinga.com
Pro-Dex Q1 EPS $0.92 Beats $0.66 Estimate, Sales $20.560M Beat $20.400M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.66 by 39.39 percent. This is a 34.29 percent decrease over earnings of $1.40 per…
4 days ago zacks.com
ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?
PDEX heads into fiscal Q1 earnings with strong medical-device sales and margin momentum, but customer concentration, a shrinking backlog and acquisition risks loom.
2 weeks ago defenseworld.net
Pro-Dex (NASDAQ:PDEX) Stock Breaks Below Two Hundred Day Moving Average – What’s Next?
Pro-Dex, Inc. (NASDAQ: PDEX - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $61.25 and…
1 month ago zacks.com
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
1 month ago zacks.com
Best Momentum Stocks to Buy for September 18th
PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th, 2026.
1 month ago zacks.com
New Strong Buy Stocks for September 18th
PGY, OPHC, PDEX, TRV and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 18th, 2026.
1 month ago defenseworld.net
Bank of New York Mellon Corp Invests $678,000 in Pro-Dex, Inc. $PDEX
Bank of New York Mellon Corp bought a new stake in shares of Pro-Dex, Inc. (NASDAQ: PDEX) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission.…
-
1 month ago benzinga.com
Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $74
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the price target from $70 to $74.
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Immuron (NASDAQ:IMRN) shares moved upwards by 48.2% to $1.65 during Friday's regular session. The market value of their outstanding shares is at $8.9 million. bioAffinity Technologies…
-
1 month ago benzinga.com
Pro-Dex Q4 EPS $0.87 Beats $0.67 Estimate, Sales $20.405M Beat $19.200M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.67 by 29.85 percent. This is a 141.67 percent increase over earnings of $0.36 per…
5 months ago seekingalpha.com
Pro-Dex: Still A Buy, But Don't Chase
Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contract now runs through December 2028, reducing potential near-term risks in that sense. Also, their…
-
5 months ago benzinga.com
Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $70
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the price target from $56 to $70.
-
6 months ago benzinga.com
Pro-Dex Q3 EPS $1.20 Beats $0.62 Estimate, Sales $19.949M Beat $17.900M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $1.20 per share which beat the analyst consensus estimate of $0.62 by 93.55 percent. This is a 22.45 percent increase over earnings of $0.98 per…
6 months ago accessnewswire.com
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026.
7 months ago defenseworld.net
Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average – Should You Sell?
Shares of Pro-Dex, Inc. (NASDAQ: PDEX - Get Free Report) passed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $38.09 and traded…
-
8 months ago benzinga.com
PRO-DEX Acquires Advanced Precision Machining; Financial Terms Not Disclosed
PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"), formerly operated as Advanced Precision Machining,…
8 months ago accessnewswire.com
Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining
IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"),…
-
9 months ago accessnewswire.com
Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
IRVINE, CA / ACCESS Newswire / January 29, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025.
9 months ago defenseworld.net
Head-To-Head Contrast: Pro-Dex (NASDAQ:PDEX) vs. STAAR Surgical (NASDAQ:STAA)
Pro-Dex (NASDAQ: PDEX - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two…
9 months ago seekingalpha.com
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount
Pro-Dex manufactures powered surgical instruments for orthopedic, CMF, and thoracic procedures. This means that PDEX effectively combines OEM programs with a smaller catalog of industrial offerings.…
9 months ago defenseworld.net
D.A. Davidson & CO. Increases Holdings in Pro-Dex, Inc. $PDEX
D.A. Davidson and CO. boosted its stake in Pro-Dex, Inc. (NASDAQ: PDEX) by 152.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
9 months ago seekingalpha.com
Pro-Dex Valuation Is Attractive Despite Customer Risk
Pro-Dex Inc. is a specialized surgical device manufacturer with strong growth, efficient capital allocation, and high customer concentration risk. PDEX trades at ~16x recurrent earnings, which is…
10 months ago defenseworld.net
Head to Head Survey: Cardinal Health (NYSE:CAH) vs. Pro-Dex (NASDAQ:PDEX)
Cardinal Health (NYSE: CAH - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on…
10 months ago defenseworld.net
Head-To-Head Review: Pro-Dex (NASDAQ:PDEX) & Spotlight Innovation (OTCMKTS:STLT)
Pro-Dex (NASDAQ: PDEX - Get Free Report) and Spotlight Innovation (OTCMKTS:STLT - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses…
10 months ago accessnewswire.com
Pro-Dex, Inc. Announces Contract Extension With Largest Customer
IRVINE, CA / ACCESS Newswire / December 19, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on December 17, 2025, it executed a contract amendment with its largest customer for an…
10 months ago defenseworld.net
Head to Head Contrast: Spotlight Innovation (OTCMKTS:STLT) versus Pro-Dex (NASDAQ:PDEX)
Spotlight Innovation (OTCMKTS:STLT - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two…
-
1 year ago benzinga.com
Pro-Dex Q1 EPS $1.40 Beats $0.50 Estimate, Sales $18.530M Beat $15.300M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $1.40 per share which beat the analyst consensus estimate of $0.50 by 180 percent. This is a 86.67 percent increase over earnings of $0.75 per…
-
1 year ago benzinga.com
Pro-Dex Issues Clarification That It Has No Affiliation Or Relationship With Polkadex, A Cryptocurrency Trading Under The Same PDEX Symbol On Certain Exchanges
PRO-DEX, INC. (NasdaqCM:PDEX) is issuing this press release in an effort to help avoid any confusion in the marketplace between the common stock of Pro-Dex, Inc., which trades on the Nasdaq Capital…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
1 year ago benzinga.com
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
-
1 year ago benzinga.com
Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $56
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the price target from $54 to $56.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
1 year ago benzinga.com
Pro-Dex Q3 EPS $0.98 Beats $0.47 Estimate, Sales $17.41M Miss $17.70M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.47 by 108.51 percent. This is a 415.79 percent increase over earnings of $0.19 per…
-
1 year ago benzinga.com
Pro-Dex Q2 EPS $0.61 Beats $0.38 Estimate, Sales $16.79M Beat $13.80M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.38 by 60.53 percent. This is a 335.71 percent increase over earnings of $0.14 per…
-
1 year ago benzinga.com
Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $52
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the price target from $30 to $52.
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
2 years ago benzinga.com
Pro-Dex Q1 2025 GAAP EPS $0.75 Beats $0.29 Estimate, Sales $14.892M Beat $12.100M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.29 by 158.62 percent. The company reported quarterly sales of $14.892 million…
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
2 years ago benzinga.com
Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday
Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday
-
2 years ago benzinga.com
Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $30
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the price target from $28 to $30.
-
2 years ago benzinga.com
Pro-Dex Q4 EPS $0.46 Beats $0.35 Estimate, Sales $15.03M Beat $10.60M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.35 by 31.43 percent. This is a 9.52 percent increase over earnings of $0.42 per…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 1043 companies hit new 52-week lows.